{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-333831","form_type":"8-K","ticker":"ALGS","cik":"0001799448","company_name":"Aligos Therapeutics, Inc.","filed_at":"2021-11-18T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.192985+00:00","generated_at":"2026-06-28T07:05:56.375725+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Aligos Therapeutics appoints Bridget Martell, M.D. to Board of Directors","bullets":["Dr. Martell appointed as Class III director; term expires at 2023 annual meeting.","She receives $35,000 annual retainer (prorated) and initial option grant of 30,000 shares.","Board size increased from seven to eight directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-333831","json":"https://secwatch.observer/filing/0001193125-21-333831.json","markdown":"https://secwatch.observer/filing/0001193125-21-333831.md","text":"https://secwatch.observer/filing/0001193125-21-333831.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799448/000119312521333831/0001193125-21-333831-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799448/000119312521333831/d437129d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T07:05:56.375725+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"61e1cfecc9","claim":"Bridget Martell was appointed as Class III director at Aligos Therapeutics, Inc..","evidence_excerpt":"appointed Bridget Martell, M.D., to the Board to fill the newly created directorship resulting from the increase in the number of authorized directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799448/000119312521333831/0001193125-21-333831-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}